Stockreport

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

LENSAR, Inc.  (LNSR) 
PDF 44 ALLY® Adaptive Cataract Treatment Systems were placed in 2023, significantly exceeding the target of 30, increasing the ALLY installed base to 54 and a backlog of 9 a [Read more]